NCT02846896
Completed
Not Applicable
The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
ConditionsPrimary Biliary Cirrhosis
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Primary Biliary Cirrhosis
- Sponsor
- Fondazione Epatocentro Ticino
- Enrollment
- 501
- Locations
- 1
- Primary Endpoint
- Prevalence of PBC in Switzerland
- Status
- Completed
- Last Updated
- 8 months ago
Overview
Brief Summary
PBC is a rare, autoimmune, cholestatic liver disease with genetic and environmental pathogenetic factors. Data about epidemiology of PBC in Switzerland are completely lacking. Epidemiology can be a powerful tool in yielding important clues as to burden and etiology of diseases. In addition, the investigators study will be the first one carried out in the country on PBC, and therefore will raise disease awareness and create a network.
Investigators
Eligibility Criteria
Inclusion Criteria
- •PBC patients living in Switzerland
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Prevalence of PBC in Switzerland
Time Frame: from 1.1.2005 until 31.12.2015
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Identification of Inflammatory and Fibrotic Biomarkers in PBC and NAFLD PatientsPrimary Biliary CirrhosisNCT02477462University of California, Davis124
Unknown
Not Applicable
Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC)Liver Cirrhosis, BiliaryBiliary Cirrhosis, PrimaryNCT00145964University Health Network, Toronto500
Completed
Phase 3
Phase 3 Study of Bezafibrate in Combination With Ursodeoxycholic Acid in Primary Biliary CirrhosisPBCNCT01654731Assistance Publique - Hôpitaux de Paris100
Unknown
Not Applicable
Family Studies in Primary Biliary Cirrhosis (PBC)Biliary Cirrhosis, PrimaryNCT00242125University Health Network, Toronto3,000
Completed
Not Applicable
Genetic Epidemiology of Primary Biliary Cirrhosis (PBC)Primary Biliary CirrhosisNCT01161953Mayo Clinic1,500